Detalhe da pesquisa
1.
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.
Br J Cancer
; 127(7): 1201-1213, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768550
2.
Increased microchimerism in peripheral blood of women with systemic lupus erythematosus: relation with pregnancy.
Clin Exp Rheumatol
; 40(11): 2153-2160, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579081
3.
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
Breast Cancer Res Treat
; 183(3): 759-770, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734520
4.
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.
Cancer Cell
; 41(5): 986-1002.e9, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116492
5.
Learning to distinguish progressive and non-progressive ductal carcinoma in situ.
Nat Rev Cancer
; 22(12): 663-678, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261705
6.
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.
NPJ Breast Cancer
; 7(1): 31, 2021 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753731
7.
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.
Am J Surg Pathol
; 43(11): 1574-1582, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206365
8.
Author Correction: Learning to distinguish progressive and non-progressive ductal carcinoma in situ.
Nat Rev Cancer
; 23(2): 112, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522469
9.
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study.
Clin Cancer Res
; 24(15): 3593-3601, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685879